Artificial intelligence (AI) and big data
AI imaging for clinical decision support
Alexios Antonopoulos, Greece
Alexios Antonopoulos, Greece
Potential of big data to improve ASCVD prediction in women
Maryam Kavousi, The Netherlands
Maryam Kavousi, The Netherlands
Atherosclerosis and liver disease
New links between atherogenic dyslipidemia and metabolic dysfunction-associated steatotic liver disease
Joel Haas, France
Joel Haas, France
New isights from Hypobetalipoproteinemia
Salvatore Petta, Italy
Salvatore Petta, Italy
Dealing with inflammation in ASCVD prevention
Pros
Paul Ridker , USA
Paul Ridker , USA
Cons
Ulrich Laufs, Germany
Ulrich Laufs, Germany
Diet and Life style in ASCVD prevention
What is the rationale for the dietary recommendations for fat intake?
Jacob J. Christensen , Norway
Jacob J. Christensen , Norway
Physical activity and ASCVD prevention: is there a dose response curve?
Signe Sørensen Torekov , Norway
Signe Sørensen Torekov , Norway
Familial hypercholesterolemia (FH) from screening to management
Monogenic vs polygenic hyperchol
Jacqueline S. Dron, USA
Jacqueline S. Dron, USA
How should we screen - systematic vs. Cascade
Tomas Freiberger, Czechia
Tomas Freiberger, Czechia
Identifying high risk patient by imaging
Universal screening in primary prevention?
Marc Dweck, UK
Marc Dweck, UK
How does SCORE2 perform in different parts of Europe and in different sub-groups?
Emanuele Di Angelantonio, UK
Emanuele Di Angelantonio, UK
Immunity and atherosclerosis
Interplay of lipoproteins with the immune response
Christoph Binder, Austria
Christoph Binder, Austria
Lipid receptors shaping immune cell functions in atherosclerosis
Sabine Steffens, Germany
Sabine Steffens, Germany
Lipid risk factors beyond LDL
Lipoprotein(a): molecular mechanisms involved in athero-thrombosis
Gilles Lambert , France
Gilles Lambert , France
Women and ASCVD
Lale Tokgözoğlu, Turkey
Lale Tokgözoğlu, Turkey
Molecular mechanisms of plaque evolution
Mechanisms of plaque progression/regression
Minna Kaikkonen- Määttä, Finland
Minna Kaikkonen- Määttä, Finland
Specific roles for PI3Ks in mechanotransduction during atherosclerosis
Muriel Laffargue, France
Muriel Laffargue, France
Obesity and cardiometabolic disease
Connecting gut hormones and lipid metabolism
Niina Matikainen, Finland
Niina Matikainen, Finland
Bariatric surgery and lipids
Geltrude Milgrone, Italy
Geltrude Milgrone, Italy
Precision medicine and ASCVD
"Primordial" prevention
Nisreen A Alwan, UK
Nisreen A Alwan, UK
Consequences of Gender Transition on ASCVD risk: a clinical perspective
Asa Tivesten, Sweden
Asa Tivesten, Sweden
Primary dyslipidaemia - new molecular targets on production and clearance
New insights in the genetics of FH
Mafalda Bourbon, Portugal
Mafalda Bourbon, Portugal
Genetics of FH in FH registry: an urgent need for an extensive cleaning
Alain Carrie, France
Alain Carrie, France
The INTERASPIRE registry - variation in care
How do TG levels vary in CVD across WHO regions
Peter Libby, USA
Peter Libby, USA
How do traditional lipids and Lp(a) differ in CVD patients across WHO regions
Kausik Ray, UK
Kausik Ray, UK
Measures of Glycaemia in CVD- How do they differ across regions
Lars Rydén, Sweden
Lars Rydén, Sweden
Characteristics of patients with CAD across WHO regions
David Wood, Ireland
David Wood, Ireland
The role of the vessel wall in atherosclerosis
Extracellular matrix
Thorsten Kessler, Germany
Thorsten Kessler, Germany
Fibroblast diversity in atherosclerosis
Judith Sluimer, The Netherlands
Judith Sluimer, The Netherlands
Triglyceride hydrolysis
The role of ANGPTL8 in the regulation of triglyceride metabolism
Robert Konrad, USA
Robert Konrad, USA
Lipoprotein lipase: How can an unstable enzyme orchestrate intravascular lipolysis?
Michael Ploug, Denmark
Michael Ploug, Denmark
